Your browser doesn't support javascript.
loading
Adenosine plasma level in patients with paroxysmal or persistent atrial fibrillation and normal heart during ablation procedure and/or cardioversion.
Maille, Baptiste; Marlinge, Marion; Vairo, Donato; Mottola, Giovanna; Koutbi, Linda; Deharo, Pierre; Gastaldi, Marguerite; Gaudry, Marine; Guiol, Claire; Bottone, Sara; Mace, Patrick; Gueant, Rosita; Chefrour, Mohamed; Martinez, Elsa; Michelet, Pierre; Gueant, Jean Louis; Boussuges, Alain; Ruf, Jean; Fenouillet, Emmanuel; Deharo, Jean Claude; Guieu, Régis; Franceschi, Frederic.
Afiliación
  • Maille B; Department of Cardiology, Timone University Hospital, 13005, Marseille, France.
  • Marlinge M; C2VN, INSERM, INRA, Aix Marseille Université, V2CN Marseille, Bvd P Dramard, 13015, Marseille, France.
  • Vairo D; C2VN, INSERM, INRA, Aix Marseille Université, V2CN Marseille, Bvd P Dramard, 13015, Marseille, France.
  • Mottola G; Laboratory of Biochemistry, Timone University Hospital, 13005, Marseille, France.
  • Koutbi L; C2VN, INSERM, INRA, Aix Marseille Université, V2CN Marseille, Bvd P Dramard, 13015, Marseille, France. guieu.regis@orange.fr.
  • Deharo P; C2VN, INSERM, INRA, Aix Marseille Université, V2CN Marseille, Bvd P Dramard, 13015, Marseille, France.
  • Gastaldi M; Laboratory of Biochemistry, Timone University Hospital, 13005, Marseille, France.
  • Gaudry M; Department of Cardiology, Timone University Hospital, 13005, Marseille, France.
  • Guiol C; C2VN, INSERM, INRA, Aix Marseille Université, V2CN Marseille, Bvd P Dramard, 13015, Marseille, France.
  • Bottone S; C2VN, INSERM, INRA, Aix Marseille Université, V2CN Marseille, Bvd P Dramard, 13015, Marseille, France.
  • Mace P; Laboratory of Biochemistry, Timone University Hospital, 13005, Marseille, France.
  • Gueant R; Department of Vascular Surgery, Timone University Hospital, Marseille, France.
  • Chefrour M; C2VN, INSERM, INRA, Aix Marseille Université, V2CN Marseille, Bvd P Dramard, 13015, Marseille, France.
  • Martinez E; Frederic II University, Naples, Italy.
  • Michelet P; Laboratory of Biochemistry, Timone University Hospital, 13005, Marseille, France.
  • Gueant JL; INSERM U 954 Nutrition Genetics - Environmental Risks, Nancy, France.
  • Boussuges A; Laboratory of Biochemistry, Timone University Hospital, 13005, Marseille, France.
  • Ruf J; Department of Cardiology, Timone University Hospital, 13005, Marseille, France.
  • Fenouillet E; C2VN, INSERM, INRA, Aix Marseille Université, V2CN Marseille, Bvd P Dramard, 13015, Marseille, France.
  • Deharo JC; Department of Emergency Medicine, Timone University Hospital, Marseille, France.
  • Guieu R; INSERM U 954 Nutrition Genetics - Environmental Risks, Nancy, France.
  • Franceschi F; C2VN, INSERM, INRA, Aix Marseille Université, V2CN Marseille, Bvd P Dramard, 13015, Marseille, France.
Purinergic Signal ; 15(1): 45-52, 2019 03.
Article en En | MEDLINE | ID: mdl-30535950
ABSTRACT
The mechanism of atrial fibrillation (AF) in patients with normal heart remains unclear. While exogenous adenosine can trigger AF, nothing is known about the behavior of endogenous adenosine plasma level (APL) at the onset of AF and during ablation procedure. Ninety-one patients (68 with paroxysmal AF 40 males, 66 ± 16 years; 23 with persistent AF 14 males, 69 ± 11 years) and 18 controls were included. Among paroxysmal patients i) medical therapy alone was performed in 45 cases and ablation procedure in 23. AF was spontaneously resolutive in 6 cases; ii) 23 underwent ablation procedure and blood was collected simultaneously in a brachial vein and in the left atrium; 17 were spontaneously in sinus rhythm while 6 were in sinus rhythm after direct current cardioversion. Among persistent patients i) in 17 patients, blood samples were collected in a brachial vein before and after direct current cardioversion; ii) in 6 patients, blood samples were collected simultaneously in a brachial vein and in left atrium before and after cardioversion during ablation procedure. CV-APL was higher in patients with persistent AF vs patients with paroxysmal AF (median [range] 0.9[0.6-1.1] vs 0.7[0.4-1.1] µM; p < 0.001). In patients with paroxysmal AF, LA-APL increased during the AF episode (0.95[0.85-1.4] vs 2.7[1.5-7] µM; p = 0.03) and normalized in sinus rhythm after DCCV. In patients with persistent AF, LA-APL was higher than CV-APL (1.2[0.7-1.8] vs 0.9[0.6-1.1] µM; p < 0.001), and both normalized in sinus rhythm (CV-APL 0.8[0.6-1.1] vs 0.75[0.4-1] µM; p = 0.03), (LA-APL 1.95[1.3-3] vs 1[0.5-1.15] µM; p = 0.03). The occurrence of AF is associated with a strong increase of APL in the atrium. The cause of this increase needs further investigations.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fibrilación Atrial / Adenosina Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Purinergic Signal Año: 2019 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fibrilación Atrial / Adenosina Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Purinergic Signal Año: 2019 Tipo del documento: Article País de afiliación: Francia